Attached files
file | filename |
---|---|
EX-31.1 - NURX PHARMACEUTICALS, INC. | v172099_ex31-1.htm |
EX-31.2 - NURX PHARMACEUTICALS, INC. | v172099_ex31-2.htm |
EX-32.1 - NURX PHARMACEUTICALS, INC. | v172099_ex32-1.htm |
10-K/A - NURX PHARMACEUTICALS, INC. | v172099_10ka.htm |
Exhibit 32.2
CERTIFICATION PURSUANT
TO
18 U.S.C. SECTION
1350,
AS ADOPTED PURSUANT
TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In connection with the annual report of
NuRx Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ending
September 30, 2009, as filed with the Securities and Exchange Commission (the
“Report”), I, Steven Gershick, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2) The information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
Date: January 28, 2010
/s/ Steven
Gershick
|
|
Name:
|
Steven
Gershick
|
Title:
|
Chief Financial
Officer
|
(principal financial
officer)
|